U.S. Markets close in 5 hrs 18 mins

How free-flowing cash is accelerating small companies' cancer drug trials

Ron Leuty
How free-flowing cash is accelerating small companies' cancer drug trials

An unprecedented biotech investment boom means smaller companies can accelerate early-stage drug trials and, potentially, carry them to more patients faster.